Literature DB >> 10217067

Spontaneous mutation spectrum at the lambda cII locus in liver, lung, and spleen tissue of Big Blue transgenic mice.

P R Harbach1, D M Zimmer, A L Filipunas, W B Mattes, C S Aaron.   

Abstract

Big Blue mice harbor a recoverable transgene in a lambda/LIZ shuttle vector. In the standard assay, in vivo mutations are measured in the bacterial lacI gene using a labor-intensive color plaque assay. Applying a simpler assay [Jakubczak et al. (1996): Proc Natl Acad Sci USA 93:9073-9078], we measured mutations in the lambda cII gene portion of the transgene. Spontaneous clear plaque mutants were analyzed from liver, lung, and spleen of five untreated mice. Of 314 mutants, 182 (58%) had independent mutations, 74 (23.5%) appeared clonal, and 58 (18.5%) showed no cII mutations. Of 182 independent cII mutations, 156 (85.7%) were base substitutions, 20 (10.9%) were frameshifts, and 6 (3.2%) were multiple substitutions and one deletion. G:C --> A:T transitions were the predominant base substitution (78% of these at CpG sites). The major mutation hotspot, a six G run and its 3' flanking T at bases 179 to 185, comprised 18.7% of the independent mutations. Other hotspots were positions 103, 196, and 212. The in vivo cII spectrum had a significantly higher proportion of G --> A and G --> T mutations and fewer frameshifts than reported in vitro. The cII and published lacI spectra are similar, though G --> A transitions and deletions were fewer in the cII gene. The cI gene was sequenced in 48 mutants with no cII mutations and most had cI mutations: 81.3% base substitutions and 18.7% frameshifts. We conclude that the cII/cI system is insensitive to deletion events, but is useful for detecting point mutations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217067     DOI: 10.1002/(sici)1098-2280(1999)33:2<132::aid-em5>3.0.co;2-2

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  9 in total

1.  Detection of mutations in transgenic fish carrying a bacteriophage lambda cII transgene target.

Authors:  R N Winn; M B Norris; K J Brayer; C Torres; S L Muller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Clusters of mutations from transient hypermutability.

Authors:  John W Drake; Anna Bebenek; Grace E Kissling; Shyamal Peddada
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

Review 3.  Too many mutants with multiple mutations.

Authors:  John W Drake
Journal:  Crit Rev Biochem Mol Biol       Date:  2007 Jul-Aug       Impact factor: 8.250

4.  The Lambda Select cII Mutation Detection System.

Authors:  Ahmad Besaratinia; Stella Tommasi
Journal:  J Vis Exp       Date:  2018-04-26       Impact factor: 1.355

5.  Environmental exposure of the mouse germ line: DNA adducts in spermatozoa and formation of de novo mutations during spermatogenesis.

Authors:  Ann-Karin Olsen; Ashild Andreassen; Rajinder Singh; Richard Wiger; Nur Duale; Peter B Farmer; Gunnar Brunborg
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

6.  Polk mutant mice have a spontaneous mutator phenotype.

Authors:  J Nicole Kosarek Stancel; Lisa D McDaniel; Susana Velasco; James Richardson; Caixia Guo; Errol C Friedberg
Journal:  DNA Repair (Amst)       Date:  2009-09-26

7.  S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver.

Authors:  James Leung; Wei Wei; Limin Liu
Journal:  Carcinogenesis       Date:  2013-01-25       Impact factor: 4.944

8.  The phage lambda CII transcriptional activator carries a C-terminal domain signaling for rapid proteolysis.

Authors:  Oren Kobiler; Simi Koby; Dinah Teff; Donald Court; Amos B Oppenheim
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-23       Impact factor: 11.205

9.  Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse.

Authors:  Raymond L Konger; Ethel Derr-Yellin; Jeffrey B Travers; Jesus A Ocana; Ravi P Sahu
Journal:  Oncotarget       Date:  2017-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.